Nasdaq
$6.48▲ 0.08%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $665.2MShares out 100M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
18- 10.6After-hours26.10.07 05:154Ownership#●●●
ACHIEVE LIFE SCIENCES, INC.
Insider Benjamin Halladay of Achieve Life Sciences reported a change in beneficial ownership of securities effective October 5, 2026. This filing is a standard Form 4 disclosure regarding insider stock transactions.…more
$6.48+0.08%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.6After-hours26.10.07 05:133Ownership
ACHIEVE LIFE SCIENCES, INC.
Benjamin Halladay, an officer of Achieve Life Sciences, has executed a Power of Attorney to authorize Sandra Thomson and Erik Atkisson to file SEC reports (Forms 3, 4, and 5) on his behalf. This is an administrative procedure granting authority for the filing of securities transaction disclosures.…more
$6.48+0.08%vs prev closeView filingShare - 10.1After-hours26.10.02 05:498-KKey event
ACHIEVE LIFE SCIENCES, INC.
Achieve Life Sciences has appointed Benjamin Halladay as the new Chief Financial Officer, effective October 5, 2026. Current CFO Mark Oki will step down on the same date, and the company confirmed that this transition is unrelated to any disagreements regarding financial statements.…more
$6.48+0.08%vs prev closeView filingShare
17 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 3d agoPre-market26.10.21 21:30#●●●#●●●
Achieve Life Sciences Reports 52-Week Cytisinicline Clinical Results
Achieve Life Sciences announced positive 52-week efficacy results from its long-term open-label trial of cytisinicline for smoking and vaping cessation. While the data shows sustained abstinence rates, the results are from an open-label study and remain subject to final regulatory approval.…more
$6.48+0.08%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 10.7Pre-market26.10.07 21:30
●●●●●●●● ●●●●● ●●●●●●
Achieve Life Sciences has appointed a new Senior Vice President of Marketing and Communications to prepare for the potential commercialization of its nicotine dependence treatment, cytisinicline. This executive hire is part of the company's broader preparations for product launch but remains a neutral development.…more
$6.48+0.08%vs prev close - 10.6After-hours26.10.07 05:02
●●●●●●●● ●●●●● ●●●●●●
Achieve Life Sciences announced the granting of stock options and restricted stock units to its new CFO and other new hires. This is a standard equity inducement plan for talent acquisition and does not impact the company's immediate financial performance.…more
$6.48+0.08%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report